Issued Patents All Time
Showing 1–21 of 21 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12173046 | TNFR2 agonists with improved stability | Roman Fischer, Martin Siegemund, Roland Kontermann | 2024-12-24 |
| 12065472 | Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivity | Roman Fischer, Roland Kontermann, Martin Siegemund | 2024-08-20 |
| 11142558 | Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivity | Roman Fischer, Roland Kontermann, Martin Siegemund | 2021-10-12 |
| 11028178 | Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (HUTNFR1) antibody | Heike Bantel, Andreas Herrmann | 2021-06-08 |
| 10864278 | Antibody-drug conjugates and immunotoxins | Roland Kontermann, Cristina Ferrer, Myriam Fabre, Laureano Simon | 2020-12-15 |
| 10808019 | Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligands | Ugur Sahin, Friederike Gieseke, Ronald Backer, Sebastian Kreiter, Roland Kontermann +2 more | 2020-10-20 |
| 10689452 | Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof | Roland Kontermann, Fabian RICHTER, Kirstin Zettlitz, Peter Scheurich, Andreas Herrmann | 2020-06-23 |
| 10570206 | Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereof | Roland Kontermann, Martin Siegemund | 2020-02-25 |
| 10428149 | Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof | Ugur Sahin, Roland Kontermann, Martin Siegemund, Meike HUTT, Oliver SEIFERT | 2019-10-01 |
| 10301368 | Cytokine fusion proteins | Ugur Sahin, Friederike Gieseke, Ronald Backer, Sebastian Kreiter, Roland Kontermann +2 more | 2019-05-28 |
| 10137202 | Antibody-drug conjugates and immunotoxins | Roland Kontermann, Cristina Ferrer, Myriam Fabre, Laureano Simon | 2018-11-27 |
| 10004812 | Antibody-drug conjugates and immunotoxins | Roland Kontermann, Cristina Ferrer, Myriam Fabre, Laureano Simon | 2018-06-26 |
| 9944708 | Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines) | Harald Wajant, Dieter Moosmayer, Thomas Wuest | 2018-04-17 |
| 9822179 | Recombinant TNF ligand family member polypeptides with antibody binding domain and uses therefor | Roland Kontermann, Martin Siegemund | 2017-11-21 |
| 9045535 | huTNFR1 selective antagonists | Peter Scheurich, Roland Kontermann, Sabine Muenkel | 2015-06-02 |
| 8980265 | Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) | Harald Wajant, Dieter Moosmayer, Thomas Wuest | 2015-03-17 |
| 8927205 | Recombinant polypeptides of the members of the TNF ligand family and use thereof | Peter Scheurich, Ingo Grunwald, Anja Krippner-Heidenreich | 2015-01-06 |
| 8859739 | Anti-huTNFR1 antibody and methods of use thereof for treatment | Roland Kontermann, Andreas Herrmann, Kirstin Zettlitz | 2014-10-14 |
| 8404238 | huTNFR1 selective antagonists | Peter Scheurich, Roland Kontermann, Sabine Münkel | 2013-03-26 |
| 7368295 | Nanoparticles comprising biologically active TNF which is immobilized on the same | Gunter Tovar, Thomas Schiestel, Herwig Brunner, Matthias Grell, Peter Scheurich +1 more | 2008-05-06 |
| 5736138 | Monoclonal antibodies with specific binding against membrane proteins on human cells, and pharmaceutical compositions containing them | Peter Scheurich, Bettina Thoma | 1998-04-07 |